We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.05B
AUM Growth
+$15.8M
Cap. Flow
-$99.8M
Cap. Flow %
-4.88%
Top 10 Hldgs %
44.82%
Holding
175
New
9
Increased
44
Reduced
72
Closed
13

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$16.8M
2
MSFT icon
Microsoft
MSFT
+$11.9M
3
ABBV icon
AbbVie
ABBV
+$11.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.03M
5
MCD icon
McDonald's
MCD
+$5.54M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$22.2M
2
ACN icon
Accenture
ACN
+$22.1M
3
META icon
Meta Platforms (Facebook)
META
+$17.5M
4
OIH icon
VanEck Oil Services ETF
OIH
+$14.9M
5
WFRD icon
Weatherford International
WFRD
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 26.62%
2 Technology 13.9%
3 Consumer Discretionary 12.79%
4 Financials 11.16%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STZ icon
101
Constellation Brands
STZ
$23.3B
$1.05M 0.05%
4,548
– –
NEOG icon
102
Neogen
NEOG
$2.53B
$1.03M 0.05%
+67,550
New +$962K
BDX icon
103
Becton Dickinson
BDX
$49.8B
$1.02M 0.05%
4,000
– –
BIDU icon
104
Baidu
BIDU
$35.3B
$1.01M 0.05%
8,829
-2,595
-23% -$265K
LOGI icon
105
Logitech
LOGI
$14.9B
$958K 0.05%
15,534
+1,000
+7% +$54.7K
BSX icon
106
Boston Scientific
BSX
$75B
$866K 0.04%
18,715
+200
+1% +$8.66K
SE icon
107
Sea Limited
SE
$77.2B
$831K 0.04%
15,968
+2,117
+15% +$114K
IBM icon
108
IBM
IBM
$223B
$826K 0.04%
5,860
– –
AMED
109
DELISTED
Amedisys
AMED
$824K 0.04%
9,863
-2,787
-22% -$251K
DBX icon
110
Dropbox
DBX
$7.41B
$815K 0.04%
36,415
– –
BMY icon
111
Bristol-Myers Squibb
BMY
$131B
$809K 0.04%
11,250
– –
LMT icon
112
Lockheed Martin
LMT
$139B
$778K 0.04%
1,600
– –
TJX icon
113
TJX Companies
TJX
$169B
$706K 0.03%
8,869
-119
-1% -$8.79K
SYK icon
114
Stryker
SYK
$131B
$621K 0.03%
2,541
+272
+12% +$61.7K
EW icon
115
Edwards Lifesciences
EW
$53.3B
$611K 0.03%
8,194
-1,741
-18% -$134K
SLB icon
116
SLB Ltd
SLB
$77.2B
$607K 0.03%
+11,350
New +$565K
GB
117
DELISTED
Global Blue Group Holding
GB
$595K 0.03%
128,571
– –
VRTX icon
118
Vertex Pharmaceuticals
VRTX
$133B
$543K 0.03%
1,881
-726
-28% -$221K
IFF icon
119
International Flavors & Fragrances
IFF
$21.4B
$541K 0.03%
5,160
+800
+18% +$78.6K
GS icon
120
Goldman Sachs
GS
$306B
$505K 0.02%
1,470
– –
XYL icon
121
Xylem
XYL
$28.1B
$489K 0.02%
4,424
+773
+21% +$81K
ETSY icon
122
Etsy
ETSY
$7.24B
$477K 0.02%
3,979
– –
SOPH icon
123
SOPHiA GENETICS
SOPH
$640M
$469K 0.02%
227,600
– –
DXCM icon
124
DexCom
DXCM
$34.3B
$452K 0.02%
3,994
-990
-20% -$109K
PODD icon
125
Insulet
PODD
$10B
$448K 0.02%
1,522
-246
-14% -$67.8K
3 4
5
6 7

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s Q4 2022 Portfolio in Review

As of Q4 2022, Bank Pictet & Cie (Europe) held 175 positions worth $2.05B, up 0.78% from $2.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Bank Pictet & Cie (Europe) withdrew a net $99.8M in Q4 2022, closing 13 positions and reducing 72 holdings. Its most notable exit was WisdomTree Europe Hedged Equity Fund, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bank Pictet & Cie (Europe) opened a new position in Neogen worth $1.03M.

  • Bank Pictet & Cie (Europe)'s largest Q4 2022 buy was Neogen: 67,550 shares worth $1.03M.
  • Bank Pictet & Cie (Europe) added most to Moderna in Q4 2022, an estimated $16.8M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $22.2M.
  • Bank Pictet & Cie (Europe) fully exited WisdomTree Europe Hedged Equity Fund in Q4 2022, selling an estimated $1.01M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 45% of its $2.05B portfolio in Q4 2022.
  • Bank Pictet & Cie (Europe) opened 9 new positions and closed 13 in Q4 2022.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 0.78% quarter-over-quarter to $2.05B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.